Deerfield Management Company, L.P. (Series C) Mannkind Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Mannkind Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 17,380 shares of MNKD stock, worth $74,734. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,380Holding current value
$74,734% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding MNKD
# of Institutions
275Shares Held
172MCall Options Held
1.37MPut Options Held
248K-
Black Rock Inc. New York, NY22.6MShares$97 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$74.5 Million0.0% of portfolio
-
State Street Corp Boston, MA9.47MShares$40.7 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$37.6 Million0.71% of portfolio
-
Nitorum Capital, L.P. New York, NY7.79MShares$33.5 Million7.16% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.11B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...